Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,889
archived clinical trials in
Blood Cancer

A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)
A Randomized, Phase II Trial Evaluating the Efficacy and Safety of Lenalidomide, Bortezomib and Dexamethasone (RVD) With or Without Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Northside Hospital Central Research Dept.
mi
from
Atlanta, GA
A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)
A Randomized, Phase II Trial Evaluating the Efficacy and Safety of Lenalidomide, Bortezomib and Dexamethasone (RVD) With or Without Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Northside Hospital Central Research Dept.
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)
A Randomized, Phase II Trial Evaluating the Efficacy and Safety of Lenalidomide, Bortezomib and Dexamethasone (RVD) With or Without Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Brooke Army Medical Center Hematology/Oncology
mi
from
San Antonio, TX
A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)
A Randomized, Phase II Trial Evaluating the Efficacy and Safety of Lenalidomide, Bortezomib and Dexamethasone (RVD) With or Without Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Brooke Army Medical Center Hematology/Oncology
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)
A Randomized, Phase II Trial Evaluating the Efficacy and Safety of Lenalidomide, Bortezomib and Dexamethasone (RVD) With or Without Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Oncology Hematology West Nebraska Cancer Specialists dbaNebraska Cancer Specialists
mi
from
Omaha, NE
A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)
A Randomized, Phase II Trial Evaluating the Efficacy and Safety of Lenalidomide, Bortezomib and Dexamethasone (RVD) With or Without Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Oncology Hematology West Nebraska Cancer Specialists dbaNebraska Cancer Specialists
mi
from
Omaha, NE
Click here to add this to my saved trials
Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)
Lenalidomide Following Rituximab and Fludarabine in Untreated Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Lombardi Cancer Center at Georgetown University Medical Center
mi
from
Washington,
Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)
Lenalidomide Following Rituximab and Fludarabine in Untreated Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Lombardi Cancer Center at Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961
A Phase 1 Extension Study to Determine the Safety of UC-961 (Cirmtuzumab) at the Recommended Phase 2 Dose for Retreatment of Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961
Status: Enrolling
Updated:  12/31/1969
UC San Diego Moores Cancer Center
mi
from
La Jolla, CA
Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961
A Phase 1 Extension Study to Determine the Safety of UC-961 (Cirmtuzumab) at the Recommended Phase 2 Dose for Retreatment of Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961
Status: Enrolling
Updated: 12/31/1969
UC San Diego Moores Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
A Pilot Feasibility Study of Metformin/Ritonavir Combination Treatment in Patients With Relapsed/Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
City of Hope Medical Center
mi
from
Duarte, CA
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
A Pilot Feasibility Study of Metformin/Ritonavir Combination Treatment in Patients With Relapsed/Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine, Siteman Cancer Center
mi
from
Saint Louis, MO
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine, Siteman Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Mt. Sinai School of Medicine
mi
from
New York, NY
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Mt. Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Multiple Ascending Dose Study of PUL-042 in Stem Cell Transplant Recipients
An Open-Label, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of PUL-042 Inhalation Solution in Subjects With Hematologic Malignancies and Recipients of Stem Cell Transplantation
Status: Enrolling
Updated:  12/31/1969
University of Texas MD Anderson MD Anderson Cancer Center
mi
from
Houston, TX
A Multiple Ascending Dose Study of PUL-042 in Stem Cell Transplant Recipients
An Open-Label, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of PUL-042 Inhalation Solution in Subjects With Hematologic Malignancies and Recipients of Stem Cell Transplantation
Status: Enrolling
Updated: 12/31/1969
University of Texas MD Anderson MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR
A Randomized Trial Comparing CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for Adults With Acute Myelogenous Leukemia Who Have Failed 1 or 2 Induction Attempts
Status: Enrolling
Updated:  12/31/1969
Universtiy of Chicago
mi
from
Chicago, IL
CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR
A Randomized Trial Comparing CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for Adults With Acute Myelogenous Leukemia Who Have Failed 1 or 2 Induction Attempts
Status: Enrolling
Updated: 12/31/1969
Universtiy of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR
A Randomized Trial Comparing CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for Adults With Acute Myelogenous Leukemia Who Have Failed 1 or 2 Induction Attempts
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR
A Randomized Trial Comparing CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for Adults With Acute Myelogenous Leukemia Who Have Failed 1 or 2 Induction Attempts
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR
A Randomized Trial Comparing CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for Adults With Acute Myelogenous Leukemia Who Have Failed 1 or 2 Induction Attempts
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR
A Randomized Trial Comparing CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for Adults With Acute Myelogenous Leukemia Who Have Failed 1 or 2 Induction Attempts
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Arizona Oncology Associates, PC - HAL
mi
from
Phoenix, AZ
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Arizona Oncology Associates, PC - HAL
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Mercy Research
mi
from
Fort Smith, AR
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Mercy Research
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Genesis Cancer Center
mi
from
Hot Springs, AR
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Genesis Cancer Center
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
St. Bernard's Medical Center
mi
from
Jonesboro, AR
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
St. Bernard's Medical Center
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
CARTI
mi
from
Little Rock, AR
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
CARTI
mi
from
Little Rock, AR
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Facey Medical Group
mi
from
Mission Hills, CA
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Facey Medical Group
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
North County Oncology
mi
from
Oceanside, CA
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
North County Oncology
mi
from
Oceanside, CA
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Ventura County Hematology Oncology Specialists
mi
from
Oxnard, CA
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Ventura County Hematology Oncology Specialists
mi
from
Oxnard, CA
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
James R. Berenson, MD, Inc
mi
from
West Hollywood, CA
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
James R. Berenson, MD, Inc
mi
from
West Hollywood, CA
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
PIH Health Hospital
mi
from
Whittier, CA
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
PIH Health Hospital
mi
from
Whittier, CA
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Centers
mi
from
Denver, CO
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Centers
mi
from
Denver, CO
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
University Cancer Institute (UCI)
mi
from
Boynton Beach, FL
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
University Cancer Institute (UCI)
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Southeast Florida Hematology Oncology Group
mi
from
Fort Lauderdale, FL
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Southeast Florida Hematology Oncology Group
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Cancer Specialists of North Florida
mi
from
Jacksonville, FL
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Cancer Specialists of North Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Watson Clinic LLP
mi
from
Lakeland, FL
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Watson Clinic LLP
mi
from
Lakeland, FL
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Ocala Oncology Center
mi
from
Ocala, FL
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Ocala Oncology Center
mi
from
Ocala, FL
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Piedmont Cancer Institute, P.C.
mi
from
Atlanta, GA
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Piedmont Cancer Institute, P.C.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Augusta University
mi
from
Augusta, GA
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Gwinnett Hospital System Inc.
mi
from
Lawrenceville, GA
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Gwinnett Hospital System Inc.
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Nancy N. and J.C. Lewis Cancer & Research Pavillion -St. Josephs Candler Health System
mi
from
Savannah, GA
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Nancy N. and J.C. Lewis Cancer & Research Pavillion -St. Josephs Candler Health System
mi
from
Savannah, GA
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Ingalls Memorial Hospital Cancer Research Center
mi
from
Harvey, IL
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Ingalls Memorial Hospital Cancer Research Center
mi
from
Harvey, IL
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Orchard Healthcare Research Inc.
mi
from
Skokie, IL
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Orchard Healthcare Research Inc.
mi
from
Skokie, IL
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Baptist Healthcare Systems, Inc. d/b/a Baptist Health Floyd
mi
from
New Albany, IN
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Baptist Healthcare Systems, Inc. d/b/a Baptist Health Floyd
mi
from
New Albany, IN
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Physicians' Clinic of Iowa, P.C at PCI Main Building
mi
from
Cedar Rapids, IA
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Physicians' Clinic of Iowa, P.C at PCI Main Building
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Commonwealth Hematology-Oncology, P.C.
mi
from
Danville, KY
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Commonwealth Hematology-Oncology, P.C.
mi
from
Danville, KY
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Hardin Memorial Hospital
mi
from
Elizabethtown, KY
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Hardin Memorial Hospital
mi
from
Elizabethtown, KY
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Kentucky Cancer Care
mi
from
Hazard, KY
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Kentucky Cancer Care
mi
from
Hazard, KY
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Oncology Associates of West Kentucky
mi
from
Paducah, KY
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Oncology Associates of West Kentucky
mi
from
Paducah, KY
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
West Kentucky Hematology-Oncology
mi
from
Paducah, KY
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
West Kentucky Hematology-Oncology
mi
from
Paducah, KY
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Pontchartrain Cancer Center
mi
from
Covington, LA
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Pontchartrain Cancer Center
mi
from
Covington, LA
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Tulane University Hospital and Clinics
mi
from
New Orleans, LA
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Tulane University Hospital and Clinics
mi
from
New Orleans, LA
Click here to add this to my saved trials
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated:  12/31/1969
Mercy Medical Center
mi
from
Baltimore, MD
Multiple Myeloma Patient Registry
Multiple Myeloma Patient Registry
Status: Enrolling
Updated: 12/31/1969
Mercy Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials